Xintela AB (publ) (STO:XINT)
Sweden · Delayed Price · Currency is SEK 0.2520
-0.0070 (-2.70%)
May 21, 2026, 12:21 PM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 223.07 million as of May 21, 2026. Its market cap has decreased by -18.28% in one year.
Market Cap
223.07M
Enterprise Value
199.86M
Revenue
2.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 223.07M, an increase of 115.15%. That is a compound annual growth rate of 7.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 223.07M | 12.28% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mendus AB | 346.01M |
| Isofol Medical AB | 244.54M |
| Xbrane Biopharma AB | 227.69M |
| Active Biotech AB | 206.93M |
| Initiator Pharma | 197.14M |
| Diamyd Medical AB | 187.53M |
| Nanologica AB | 164.38M |
| AlzeCure Pharma AB | 160.31M |